ONCOLOGIST is a premier, open-access journal published by Oxford University Press, advancing the field of cancer research since its inception in 1996. With an impressive H-Index and a prestigious placement within the Q1 category in Cancer Research, Medicine, and Oncology for 2023, ONCOLOGIST stands at the forefront of oncological science, boasting a Scopus rank of #55 out of 404 in Medicine and #47 out of 230 in Cancer Research. This journal not only disseminates cutting-edge research but also aims to foster multidisciplinary approaches that are critical for addressing the complex challenges faced in cancer therapy and survivorship. Be part of a vibrant community as you explore impactful research articles that contribute to the global conversation on cancer. ONCOLOGIST is dedicated to providing an accessible platform for authors and readers alike, ensuring that high-quality research is available to all stakeholders in the fight against cancer.

Cancer Management and Research, published by DOVE MEDICAL PRESS LTD, is a leading open-access journal dedicated to advancing the field of oncology. Since its inception in 2009, this journal has established itself as a vital resource for researchers, clinicians, and healthcare professionals focused on cancer treatment and management. With its robust impact factor and impressive Scopus ranking in the 77th percentile of oncology medicine, it provides a prominent platform for sharing high-quality research. The journal covers a wide range of topics within cancer management, including innovative therapeutic strategies, clinical trials, patient care, and health policy, ensuring a comprehensive approach to current challenges in the field. Operating from New Zealand, it invites contributions that can shape the future of oncology and improve patient outcomes globally, making it an essential addition to the libraries of those engaged in cancer research and practice.

Welcome to JCO Clinical Cancer Informatics, an esteemed journal at the forefront of the intersection between oncology and health informatics. Published by Lippincott Williams & Wilkins, this journal is dedicated to advancing the understanding and application of cancer data through innovative informatics solutions. Since its inception in 2017, JCO Clinical Cancer Informatics has established itself as a critical resource for researchers, practitioners, and students, as evidenced by its high rankings in the 2023 Scimago Quartiles—Q2 in Cancer Research and Q1 in both Health Informatics and Oncology. With a commitment to open access, this journal aims to disseminate groundbreaking research findings that enhance cancer care and inform public health strategies. Positioned in the United States, it serves as a pivotal platform for sharing knowledge and fostering collaboration within the global cancer research community.

JMIR Research Protocols, published by JMIR PUBLICATIONS, INC, is a leading open-access journal that has been at the forefront of advancing research methodologies since its inception in 2012. With its ISSN 1929-0748, this journal is dedicated to providing a platform for the publication of innovative study protocols in the field of medicine, ensuring rigorous peer review and promoting transparency in research practices. Based in Canada, the journal has steadily gained recognition, currently holding a prominent position in the Q3 category of Medicine (Miscellaneous), with an impressive Scopus rank of #211 out of 636, placing it in the 66th percentile of its field. Researchers and professionals will find that JMIR Research Protocols not only supports the open sharing of knowledge but also enhances collaboration among the scientific community. Its open-access policy ensures broader dissemination of research findings, making it an essential resource for anyone interested in the evolving landscape of medical research methodologies.

Asia-Pacific Journal of Clinical Oncology is an essential publication within the field of medical oncology, dedicated to advancing the understanding and treatment of cancer through rigorous research and innovative clinical practices. Published by WILEY, this journal has established itself as a significant resource for researchers, healthcare professionals, and students interested in the latest findings across the Asia-Pacific region and beyond. With a respectable impact factor and categorized within the Q2 and Q3 quartiles of Medicine (miscellaneous) and Oncology respectively, the journal aims to disseminate knowledge on diverse aspects of clinical oncology, promoting the improvement of patient care and treatment outcomes. The Asia-Pacific Journal of Clinical Oncology, operating from the United Kingdom, invites contributions that highlight significant findings and advancements in oncology, making it a crucial platform for collaboration and knowledge sharing in this vital field of medicine.

JOURNAL OF MEDICAL INTERNET RESEARCH, published by JMIR PUBLICATIONS, INC, stands as a pivotal resource in the field of Health Informatics, with an esteemed ranking of #7 out of 138 in the Scopus database, placing it in the top 95th percentile. Since its inception in 1999, this Open Access journal has been committed to disseminating high-quality, peer-reviewed research that explores the intersection of healthcare and internet technologies. With its headquarters in Toronto, Canada, the journal encompasses a broad range of topics, including eHealth, telemedicine, and mobile health innovations. The impact factor and its Q1 quartile ranking highlight the journal's significant influence and prevalence in advancing the understanding of digital health landscapes. Researchers, professionals, and students alike benefit from its valuable insights, making the JOURNAL OF MEDICAL INTERNET RESEARCH an essential tool for fostering informed practices and policy-making in the rapidly evolving domain of health informatics.

CANCER, published by Wiley, stands as a pivotal journal in the field of oncology and cancer research, boasting an impressive impact factor and consistently dynamic growth since its inception in 1948. With an ISSN of 0008-543X and an E-ISSN of 1097-0142, this esteemed journal is recognized for its rigorous peer-reviewed articles, making significant contributions to the understanding of cancer biology, treatment modalities, and clinical practices. CANCER holds a distinguished position in the academic community, securing its placement in the Q1 category for both cancer research and oncology, and ranks within the top percentiles on Scopus, indicating its high impact and relevance. The journal is particularly beneficial for researchers, professionals, and students seeking to stay abreast of the latest advancements in cancer science. By addressing essential research questions and providing pathways for new therapies, CANCER continues to play a crucial role in shaping the future of oncology and improving patient outcomes.

The JOURNAL OF CANCER EDUCATION, published by SPRINGER, stands as a pivotal resource in the fields of oncology and public health. With an ISSN of 0885-8195 and an E-ISSN of 1543-0154, this esteemed journal has been disseminating vital research since 1986 and continues to play a crucial role in advancing knowledge until 2024. Recognized in 2023 with a Q3 rating in Oncology and a Q2 rating in Public Health, it reflects a solid standing in an ever-evolving academic landscape. The journal ranks #297 out of 665 in the Public Health category and #233 out of 404 in Oncology, showcasing its contribution to the scientific community. Aimed at researchers, practitioners, and students alike, the journal invites submissions that enhance understanding of cancer education, prevention, and management, ensuring that the knowledge shared is both impactful and accessible. With its focus on evidence-based practices and innovative educational strategies in cancer care, the JOURNAL OF CANCER EDUCATION serves as an essential platform for fostering collaboration and progress in oncology education.

Medical Oncology, published by Humana Press Inc, stands as a significant contributor to the field of oncology, with its long-standing commitment to disseminating research and clinical findings relevant to the treatment and management of cancer. Established in 1994 and continuing through 2024, this journal publishes insightful articles that reflect the latest advancements in cancer research, hematology, and related medical fields. With an evolving impact factor and remarkable categorizations, including Q3 in Cancer Research and Q2 in both Hematology and Oncology, Medical Oncology serves as a pivotal resource for healthcare providers, researchers, and students dedicated to improving cancer outcomes. Although it does not offer open access, the journal is widely recognized for its rigorous peer-review process and high-quality publications, making it an essential platform for sharing innovative research and critical reviews in oncology.

Welcome to the International Journal of E-Health and Medical Communications, a pivotal publication designed to bridge the gap between health informatics and computer science applications. Published by IGI Global, this journal serves as a platform for innovative research and insights into e-health technologies, health communication strategies, and the evolving role of digital tools in enhancing healthcare delivery and management. With an ISSN of 1947-315X and E-ISSN 1947-3168, it caters to an audience keen on advancing the intersection of technology and health, as evidenced by its respectable standings in Scopus rankings—positioned in the 64th percentile in Health Informatics and 63rd in Computer Science Applications. Over its publication history from 2010 to 2024, the journal has consistently contributed to significant discussions and advancements within these fields, highlighted by its Q3 quartile ranking in 2023. Join a community of researchers, professionals, and students dedicated to the ongoing exploration of e-health, as we collectively navigate the complex landscape of healthcare innovation.